dpp4 and glp-1 Neuroprotection by dipeptidyl-peptidase-4 inhibitors glucagon-like peptide-1 analogs via the modulation of AKT-signaling pathway in Alzheimer's disease GLP-1 Receptor Agonists | New

Indian journal of physiology and pharmacology

INS-1 832/3 were maintained in RPMI-1640 at 11 mM d-glucose, supplemented with 10% fetal bovine serum (FBS), 10 mM HEPES, 2 mM l-glutamine, 1 mM pyruvate, 50 M -mercaptoethanol, and 1% penicillin/streptomycin 21

A better understanding of the background biology will provide rationales for utilizing new compounds such as progesterone receptor modulators in the relevant conditions

While efficacy matters, the tolerability and adverse effect profile often determines whether a treatment is suitable for long-term use

Konopleva M, Zhao S, Jiang S, Snell V, Zhang X, Reed JC, Andreeff M

Cyanocobalamin is a stable, synthetic form of B12